Current Advances in COPD Imaging

Overview

Journal Acad Radiol

Specialty Radiology

Date 2018 Aug 11

PMID 30093217

Citations 5

Authors

Jeffrey Thiboutot

Wu Yuan

Hyeon-Cheol Park

Andrew D Lerner

Wayne Mitzner

Lonny B Yarmus

Xingde Li

Robert H Brown

Affiliations

Soon will be listed here.

Abstract

Objective: To review the recent advances in available technologies for imaging COPD and present the novel optical coherence tomography (OCT) airway imaging technology.

Materials And Methods: This is an unstructured review of published evidence of available pulmonary imaging technologies along with a demonstration of state-of-the-art OCT imaging technology of in vivo human and animal airways.

Results: Advanced imaging techniques such as Magnetic Resonance (MR) imaging using hyperoloarized noble gases, micro-Computed Tomography (micro-CT), and OCT aim to further our understanding of COPD. Lung densitometry can aid in identifying an exacerbation prone phenotype which may have implications for targeting specific therapies to these individuals. MR ventilation scans have the ability to provide a functional and regional distribution of airflow obstruction offering insight into the airway and parenchymal changes induced by COPD. Micro-CT gives a near microscopic view of the terminal bronchioles and alveoli permitting study of the microarchitecture of the lung ex vivo. Optical coherence tomography can visualize the microstructure of the airway walls (epithelium, smooth muscle, blood vessels, cartilage) permitting real time in vivo as well as longitudinal evaluation of airway changes in patients with COPD.

Conclusion: Advanced imaging techniques play a vital role in expanding our current understanding of COPD.

Citing Articles

Optimizing the Yield of Abnormal Preoperative Chest Radiographs in Elective Non-cardiothoracic Surgery: Development of a Risk Prediction Score and External Validation.

Seangleulur A, Thakkinstian A, Supaopaspan W, Kwankua A, Sukkasem W, Kunawudhi A World J Surg. 2023; 47(11):2698-2707.

PMID: 37674044 DOI: 10.1007/s00268-023-07146-7.

Current Perspectives of Pharmacotherapies for COPD.

Pleasants R, Donohue J Respir Care. 2023; 68(7):927-938.

PMID: 37353337 PMC: 10289617. DOI: 10.4187/respcare.10952.

Lung Imaging in COPD Part 2: Emerging Concepts.

Raoof S, Shah M, Braman S, Agrawal A, Allaqaband H, Bowler R Chest. 2023; 164(2):339-354.

PMID: 36907375 PMC: 10475822. DOI: 10.1016/j.chest.2023.02.049.

A high-resolution 3D atlas of the spectrum of tuberculous and COVID-19 lung lesions.

Wells G, Glasgow J, Nargan K, Lumamba K, Madansein R, Maharaj K EMBO Mol Med. 2022; 14(11):e16283.

PMID: 36285507 PMC: 9641421. DOI: 10.15252/emmm.202216283.

Advances in Chronic Obstructive Pulmonary Disease Imaging.

Dolliver W, Diaz A Barc Respir Netw Rev. 2021; 6(2):128-143.

PMID: 33758787 PMC: 7983592. DOI: 10.23866/brnrev:2019-0023.

References

Woods J, Choong C, Yablonskiy D, Bentley J, Wong J, Pierce J . Hyperpolarized 3He diffusion MRI and histology in pulmonary emphysema. Magn Reson Med. 2006; 56(6):1293-300. PMC: 2230620. DOI: 10.1002/mrm.21076. View

Dirksen A, Friis M, Olesen K, Skovgaard L, Sorensen K . Progress of emphysema in severe alpha 1-antitrypsin deficiency as assessed by annual CT. Acta Radiol. 1997; 38(5):826-32. DOI: 10.1080/02841859709172418. View

McDonough J, Yuan R, Suzuki M, Seyednejad N, Elliott W, Sanchez P . Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011; 365(17):1567-75. PMC: 3238466. DOI: 10.1056/NEJMoa1106955. View

Ford E . Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001-2012 and Nationwide Emergency Department Sample 2006-2011. Chest. 2014; 147(4):989-998. PMC: 4589247. DOI: 10.1378/chest.14-2146. View

Nakano Y, Wong J, de Jong P, Buzatu L, Nagao T, Coxson H . The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med. 2004; 171(2):142-6. DOI: 10.1164/rccm.200407-874OC. View

Kirby M, Svenningsen S, Owrangi A, Wheatley A, Farag A, Ouriadov A . Hyperpolarized 3He and 129Xe MR imaging in healthy volunteers and patients with chronic obstructive pulmonary disease. Radiology. 2012; 265(2):600-10. DOI: 10.1148/radiol.12120485. View

Driehuys B, Cofer G, Pollaro J, Mackel J, Hedlund L, Johnson G . Imaging alveolar-capillary gas transfer using hyperpolarized 129Xe MRI. Proc Natl Acad Sci U S A. 2006; 103(48):18278-83. PMC: 1838742. DOI: 10.1073/pnas.0608458103. View

Hurst J, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R . Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010; 363(12):1128-38. DOI: 10.1056/NEJMoa0909883. View

Coxson H, Nasute Fauerbach P, Storness-Bliss C, Muller N, Cogswell S, Dillard D . Computed tomography assessment of lung volume changes after bronchial valve treatment. Eur Respir J. 2008; 32(6):1443-50. DOI: 10.1183/09031936.00056008. View

10.

Jang I, Bouma B, Park S, Park S, Seung K, Choi K . Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound. J Am Coll Cardiol. 2002; 39(4):604-9. DOI: 10.1016/s0735-1097(01)01799-5. View

11.

Fishman A, Martinez F, Naunheim K, Piantadosi S, Wise R, Ries A . A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003; 348(21):2059-73. DOI: 10.1056/NEJMoa030287. View

12.

Kirby M, Pike D, Coxson H, McCormack D, Parraga G . Hyperpolarized (3)He ventilation defects used to predict pulmonary exacerbations in mild to moderate chronic obstructive pulmonary disease. Radiology. 2014; 273(3):887-96. DOI: 10.1148/radiol.14140161. View

13.

Gu S, Leader J, Zheng B, Chen Q, Sciurba F, Kminski N . Direct assessment of lung function in COPD using CT densitometric measures. Physiol Meas. 2014; 35(5):833-45. PMC: 4145588. DOI: 10.1088/0967-3334/35/5/833. View

14.

Kirby M, Mathew L, Wheatley A, Santyr G, McCormack D, Parraga G . Chronic obstructive pulmonary disease: longitudinal hyperpolarized (3)He MR imaging. Radiology. 2010; 256(1):280-9. DOI: 10.1148/radiol.10091937. View

15.

Gordon S, Bruce N, Grigg J, Hibberd P, Kurmi O, Hubert Lam K . Respiratory risks from household air pollution in low and middle income countries. Lancet Respir Med. 2014; 2(10):823-60. PMC: 5068561. DOI: 10.1016/S2213-2600(14)70168-7. View

16.

Kaplan T, Atac G, Gunal N, Kocer B, Alhan A, Cubuk S . Quantative computerized tomography assessment of lung density as a predictor of postoperative pulmonary morbidity in patients with lung cancer. J Thorac Dis. 2015; 7(8):1391-7. PMC: 4561281. DOI: 10.3978/j.issn.2072-1439.2015.07.26. View

17.

Tanabe N, Muro S, Hirai T, Oguma T, Terada K, Marumo S . Impact of exacerbations on emphysema progression in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011; 183(12):1653-9. DOI: 10.1164/rccm.201009-1535OC. View

18.

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

19.

Coxson H, Dirksen A, Edwards L, Yates J, Agusti A, Bakke P . The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study. Lancet Respir Med. 2014; 1(2):129-36. DOI: 10.1016/S2213-2600(13)70006-7. View

20.

Yanai M, Sekizawa K, Ohrui T, Sasaki H, Takishima T . Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol (1985). 1992; 72(3):1016-23. DOI: 10.1152/jappl.1992.72.3.1016. View